Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Bellance 2009 Int J Biochem Cell Biol"

From Bioblast
 
(3 intermediate revisions by 3 users not shown)
Line 7: Line 7:
|abstract=Little is known on the metabolic profile of lung tumors and the reminiscence of embryonic features. Herein, we determined the bioenergetic profiles of human fibroblasts taken from lung epidermoid carcinoma (HLF-a) and fetal lung (MRC5). We also analysed human lung tumors and their surrounding healthy tissue from four patients with adenocarcinoma. On these different models, we measured functional parameters (cell growth rates in oxidative and glycolytic media, respiration, ATP synthesis and PDH activity) as well as compositional features (expression level of various energy proteins and upstream transcription factors). The results demonstrate that both the lung fetal and cancer cell lines produced their ATP predominantly by glycolysis, while oxidative phosphorylation was only capable of poor ATP delivery. This was explained by a decreased mitochondrial biogenesis caused by a lowered expression of [[PGC1α]] (as shown by RT-PCR and Western blot) and mtTFA. Consequently, the relative expression of glycolytic versus OXPHOS markers was high in these cells. Moreover, the re-activation of mitochondrial biogenesis with resveratrol induced cell death specifically in cancer cells. A consistent reduction of mitochondrial biogenesis and the subsequent alteration of respiratory capacity was also observed in lung tumors, associated with a lower expression level of bcl2. Our data give a better characterization of lung cancer cells' metabolic alterations which are essential for growth and survival. They designate mitochondrial biogenesis as a possible target for anti-cancer therapy.
|abstract=Little is known on the metabolic profile of lung tumors and the reminiscence of embryonic features. Herein, we determined the bioenergetic profiles of human fibroblasts taken from lung epidermoid carcinoma (HLF-a) and fetal lung (MRC5). We also analysed human lung tumors and their surrounding healthy tissue from four patients with adenocarcinoma. On these different models, we measured functional parameters (cell growth rates in oxidative and glycolytic media, respiration, ATP synthesis and PDH activity) as well as compositional features (expression level of various energy proteins and upstream transcription factors). The results demonstrate that both the lung fetal and cancer cell lines produced their ATP predominantly by glycolysis, while oxidative phosphorylation was only capable of poor ATP delivery. This was explained by a decreased mitochondrial biogenesis caused by a lowered expression of [[PGC1α]] (as shown by RT-PCR and Western blot) and mtTFA. Consequently, the relative expression of glycolytic versus OXPHOS markers was high in these cells. Moreover, the re-activation of mitochondrial biogenesis with resveratrol induced cell death specifically in cancer cells. A consistent reduction of mitochondrial biogenesis and the subsequent alteration of respiratory capacity was also observed in lung tumors, associated with a lower expression level of bcl2. Our data give a better characterization of lung cancer cells' metabolic alterations which are essential for growth and survival. They designate mitochondrial biogenesis as a possible target for anti-cancer therapy.
|keywords=Lung tumors, Bioenergetics, Mitochondria, Oxidative phosphorylation
|keywords=Lung tumors, Bioenergetics, Mitochondria, Oxidative phosphorylation
|mipnetlab=CZ_Prague_Jezek P, FR_Bordeaux_Rossignol R
|mipnetlab=CZ Prague Jezek P, FR Bordeaux Rossignol R
|discipline=Biomedicine
|discipline=Biomedicine
}}
}}
{{Labeling
{{Labeling
|area=Respiration, mt-Biogenesis;mt-density, Genetic knockout;overexpression, mt-Medicine
|area=Respiration, mt-Biogenesis;mt-density, Genetic knockout;overexpression, mt-Medicine, Pharmacology;toxicology
|diseases=Cancer
|organism=Human
|organism=Human
|model cell lines=Fibroblast
|tissues=Fibroblast
|preparations=Intact organ, Intact cells
|preparations=Intact organ, Intact cells
|diseases=Cancer
|topics=ADP, Substrate
|topics=ADP, Substrate
|couplingstates=OXPHOS
|couplingstates=OXPHOS
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Resveratrol,
|discipline=Biomedicine
|discipline=Biomedicine
}}
}}

Latest revision as of 07:23, 21 February 2020

Publications in the MiPMap
Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77.

» PMID: 19712747

Bellance N, Benard G, Furt F, Begueret H, Smolkova K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Int J Biochem Cell Biol

Abstract: Little is known on the metabolic profile of lung tumors and the reminiscence of embryonic features. Herein, we determined the bioenergetic profiles of human fibroblasts taken from lung epidermoid carcinoma (HLF-a) and fetal lung (MRC5). We also analysed human lung tumors and their surrounding healthy tissue from four patients with adenocarcinoma. On these different models, we measured functional parameters (cell growth rates in oxidative and glycolytic media, respiration, ATP synthesis and PDH activity) as well as compositional features (expression level of various energy proteins and upstream transcription factors). The results demonstrate that both the lung fetal and cancer cell lines produced their ATP predominantly by glycolysis, while oxidative phosphorylation was only capable of poor ATP delivery. This was explained by a decreased mitochondrial biogenesis caused by a lowered expression of PGC1α (as shown by RT-PCR and Western blot) and mtTFA. Consequently, the relative expression of glycolytic versus OXPHOS markers was high in these cells. Moreover, the re-activation of mitochondrial biogenesis with resveratrol induced cell death specifically in cancer cells. A consistent reduction of mitochondrial biogenesis and the subsequent alteration of respiratory capacity was also observed in lung tumors, associated with a lower expression level of bcl2. Our data give a better characterization of lung cancer cells' metabolic alterations which are essential for growth and survival. They designate mitochondrial biogenesis as a possible target for anti-cancer therapy. Keywords: Lung tumors, Bioenergetics, Mitochondria, Oxidative phosphorylation

O2k-Network Lab: CZ Prague Jezek P, FR Bordeaux Rossignol R


Labels: MiParea: Respiration, mt-Biogenesis;mt-density, Genetic knockout;overexpression, mt-Medicine, Pharmacology;toxicology  Pathology: Cancer 

Organism: Human  Tissue;cell: Fibroblast  Preparation: Intact organ, Intact cells 

Regulation: ADP, Substrate  Coupling state: OXPHOS 

HRR: Oxygraph-2k 

Resveratrol